Some up-and-coming angel investors
Dozens of people in the Indianapolis area have the potential and the interest to become angel investors in the next few years.
Home » Search
Search Results
4,410 results for '\"eli lilly\"'
- Sort By
-
Date
- Any Time
- Past Day
- Past Week
- Past Month
- Past Year
-
Custom Date Range
Articles
Indianapolis set for next wave of angel investors
A wave of up-and-coming angel investors in the Indianapolis area are quietly accumulating the expertise and thick wallets
necessary to back startups that are at once risky and rich with potential for lucrative returns.Lilly wins court ban on generic copy of Gemzar
Eli Lilly and Co. won a U.S. court ruling Wednesday that bars Teva Pharmaceutical Industries Ltd. from selling a generic version
of the cancer drug Gemzar until November.Lilly drug wins U.K. backing as cancer therapy
Eli Lilly and Co.’s Alimta has received the preliminary backing of a United Kingdom agency as a maintenance treatment for
patients with the most common form of lung cancer.Roll of dice turns out nice for Butler’s Stevens
The biggest chance Brad Stevens ever took, the best game plan he ever drew up, had nothing to do with a prized recruit or
some brilliant set of Xs and Os scrawled out on a greaseboard. It came on the day he decided to quit his job at Eli Lilly
and
Co. and to pursue his first love, basketball.
Lilly to let 115 workers go in new outsourcing deal
Deal with unit of Massachusetts-based Thermo Fisher Scientific would keep many of the employees working in same
location.New Indy Hub Web site markets city to young professionals
The site, created by TrendyMinds, is aimed at out-of-town job candidates, who might be unaware of the city’s cultural
and entertainment offerings.Downtown buildings land arts tenants
Vonnegut Memorial Library Inc. will move into 1,100 square feet at 340 N. Senate Ave. The Arts Council of Indianapolis will
occupy 5,400 square feet at 922 N. Pennsylvania St.Lilly eyes more animal-health acquisitions
Eli Lilly is interested in assets that may be offered for sale as a result of Sanofi-Aventis SA and Merck & Co.’s plan to
combine their veterinary units.Lilly sues Hospira over generic version of Gemzar
Indianapolis-based Eli Lilly and Co. sued rival drugmaker Hospira Inc. to prevent it from selling a generic version of the
cancer drug Gemzar before a patent on the medicine expires in 2013.Lilly Endowment’s assets drop more than foundation peers
Once the nation’s wealthiest foundation, Indianapolis-based Lilly Endowment now ranks ninth among its grant-making
peers. The endowment’s value fell 15 percent last year, to an estimated $4.8 billion.People
John Lechleiter, CEO of Eli Lilly and Co., was elected treasurer of the board of PhRMA, the powerful industry
association that represents large pharmaceutical and biotech companies. Lechleiter has been on the board of PhRMA for two
years.Indianapolis-based Simon Property Group Inc. named former WellPoint Inc. CEO Larry Glasscock to its board
of directors. Glasscock, 61, also serves as a director at Warsaw-based Zimmer Holdings Inc. and Sprint Nextel Corp.The Indiana Health Industry Forum elected two members to its board of directors: Mark Deuser, CEO of Techshot,
a technology development company based in Greenville, and Todd Vare, an intellectual-property attorney at
the Indianapolis law firm Barnes & Thornburg LLP.Company news
You win some, you lose some, and you go to court again. That was the story for Eli Lilly and Co. in the
past week. The Indianapolis-based drugmaker suffered the biggest theft of pharmaceuticals in history when $75 million worth
of drugs were stolen from a Connecticut warehouse. The company expects its insurance to cover the losses. Meanwhile, Lilly
won a court appeal against Massachusetts-based Ariad Pharmaceuticals Inc., according to Bloomberg News. That decision nullified
a $65.2 million verdict won by Ariad for royalties on Lilly’s osteoporosis drug Evista and sepsis medicine Xigris. But
Lilly plunged into a new patent dispute, this time suing the U.S. unit of Dutch drugmaker Synthon BV to prevent it from selling
a generic version Adcirca. The drug, which was approved last year, uses the same active ingredient as Lilly’s anti-impotence
pill Cialis to treat lung problems.The Fairbanks Institute for Healthy Communities has created a repository in Indianapolis for scientists
to research diseases associated with aging and ideally help develop more effective medicines. The INbank stores biological
samples along with the history and clinical outcome of the corresponding patient.The Alfred Mann Institute for Biomedical Development in West Lafayette is funding work by two Purdue University
professors that could allow for almost immediate readings on the concentration of a drug in a patient’s blood. The technology,
being developed by Zheng Ouyang, a professor of biomedical engineering, and R. Graham Cooks, an analytical chemistry professor,
could be used in hospitals, doctor's offices or as part of clinical trials. Also, by not sending the blood sample to an
off-site lab, the test could cost far less.Indianapolis-based Diversity Accords LLC and the Indiana Health Industry Forum have formed
a partnership to help minority-owned suppliers identify and respond to opportunities within the health and life sciences industries.
Members of the Health Industry Forum can receive a discount off Diversity Accords’ monthly association fee. Diversity
Accords has been tapped by such companies as Illinois-based Hospira Inc. and California-based Kaiser-Permanente to meet their
objectives on using minority-owned companies as suppliers.
Bill kicks off years of change for local health care players
Sweeping changes phase in slowly for most, but insurers, hospitals, drug companies, employers, workers, medical device makers
and more will eventually feel impact.Reform offers risk, opportunities for Lilly, WellPoint
Drugmakers and insurers could gain millions of customers under the legislation, but the industry also will pay new fees and
face stricter rules that may shrink profit and fuel mergers.What’s next for guns at work
Beginning July 1, employees will be able to bring guns to work. A labor lawyer says employers will need to get creative.
Lilly shareholders deserve protection
This is the wrong time, in my opinion, and I may not have all the facts, to open up Eli Lilly to an outside takeover.
Indy Partnership aims to double economic development deals
The organization last year closed 11 business expansion or attraction deals, netting 2,950 new jobs in the process.